MRVI
Maravai LifeSciences Exceeds Expectations with 10% Year-Over-Year Revenue Growth in Q3 2026
Maravai LifeSciences, a leading provider of contract research and development services, has reported an impressive performance in the third quarter of 2026. According to the company's earnings call transcript, Maravai generated revenue of $45.9 million, representing a 10% year-over-year growth. The company's CEO, Bernd Brust,